Tools to analyze protein farnesylation in cells

被引:41
作者
Troutman, JM
Roberts, MJ
Andres, DA
Spielmann, HP [1 ]
机构
[1] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA
[3] Univ Kentucky, Kentucky Ctr Struct Biol, Lexington, KY 40536 USA
关键词
D O I
10.1021/bc050068+
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Farnesylation of proteins is catalyzed by protein farnesyl transferase (FTase) and is obligatory for the function of the oncoprotein Ras and a variety of other physiologically important proteins. The rapid and selective detection of cellular protein farnesylation status is crucial to understanding both the function of farnesylated proteins and FTase inhibitors. The unnatural FPP analogue 8-ani-linogeranyl diphosphate (AGPP, 3b) is an effective alternative substrate for mammalian FTase. Using antibodies specific for the anilinogeranyl moiety, we show that the alcohol precursor (AGOH, 5b) of AGPP is incorporated into cellular proteins in an FTase dependent manner competitive with endogenous pools of FPP. Continuous treatment of HEK-293 cells with 100 mu M AGOH for up to 3 days is neither cytotoxic or cytostatic. Antibodies to detect the unnatural anilinogeranyl group were raised against bovine serum albumin (BSA) and keyhole limpet hemocyanin (KLH) bioconjugates of the activated hapten N-hydroxyphthalimido-succinyl-(S-anilinogeranyl)-(L)-cysteine methyl ester 9a. Polyclonal antisera containing anti-anilinogeranyl antibodies were generated by immunization of rabbits and a monoclonal anti-anilinogeranyl antibody was raised in mice. ELISA and western blotting of anilinogeranyl modified proteins were used to show the selectivity and measure the titer of the antibodies. The unnatural FPP analogue and corresponding antibodies provide a simple and rapid method for monitoring FTase activity in cells and detection of cellular proteins modified by AGOH 5a.
引用
收藏
页码:1209 / 1217
页数:9
相关论文
共 54 条
[1]   An overview of farnesyltransferase inhibitors and their role in lung cancer therapy [J].
Adjei, AA .
LUNG CANCER, 2003, 41 :S55-S62
[2]   Blocking oncogenic Ras signaling for cancer therapy [J].
Adjei, AA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14) :1062-1074
[3]   Expression cloning of a novel farnesylated protein, RDJ2, encoding a DnaJ protein homologue [J].
Andres, DA ;
Shao, HP ;
Crick, DC ;
Finlin, BS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 346 (01) :113-124
[4]  
Andres DA, 1999, METH MOL B, V116, P107
[5]  
ANTUCCI R, 2003, CANC CONTROL, V10, P384
[6]  
ANWAR K, 1992, CANCER RES, V52, P5991
[7]   Biological effects and mechanism of action of farnesyl transferase inhibitors [J].
Ashar, HR ;
Armstrong, L ;
James, LJ ;
Carr, DM ;
Gray, K ;
Taveras, A ;
Doll, RJ ;
Bishop, WR ;
Kirschmeier, PT .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (10) :949-952
[8]   RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein:: Evidenced in vivo by an anti-farnesyl cysteine antibody [J].
Baron, R ;
Fourcade, E ;
Lajoie-Mazenc, I ;
Allal, C ;
Couderc, B ;
Barbaras, R ;
Favre, G ;
Faye, JC ;
Pradines, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11626-11631
[9]   INTERACTION OF GLUCOCORTICOID ANALOGS WITH THE HUMAN GLUCOCORTICOID RECEPTOR [J].
BERGER, TS ;
PARANDOOSH, Z ;
PERRY, BW ;
STEIN, RB .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :733-738
[10]   Absence of the CAAX endoprotease Rce1: Effects on cell growth and transformation [J].
Bergo, MO ;
Ambroziak, P ;
Gregory, C ;
George, A ;
Otto, JC ;
Kim, E ;
Nagase, H ;
Casey, PJ ;
Balmain, A ;
Young, SG .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) :171-181